Pemazyre 9 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DR26FCP6E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,916
Award facts
- Contract value 100% obligated
- $12,916.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Pemazyre 9 mg tablets in quantities of 14 units. This non-set-aside competitive award carries a ceiling value of $12,916.09 and is structured as a firm fixed price delivery order, with an ultimate completion date of December 9, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains, from specialty medications to generic drugs and medical supplies. This particular delivery order for Pemazyre, an oncology medication, reflects the company's role within the DLA's Medical Supply Chain in fulfilling specialized pharmaceutical requirements for Defense Health Agency customers and other federal healthcare programs. The non-set-aside status of this award underscores AmerisourceBergen's competitive standing among federal pharmaceutical vendors.
Quick answers
Who was awarded contract SPE2DR26FCP6E?
SPE2DR26FCP6E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FCP6E worth?
The government has obligated $12,916 on SPE2DR26FCP6E.
Is contract SPE2DR26FCP6E an order under another contract?
Yes. SPE2DR26FCP6E is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCP6E competed?
The extent of competition for SPE2DR26FCP6E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award